These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31306749)

  • 41. Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2012 Oct; 101(10):3593-603. PubMed ID: 22786667
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modeling gastrointestinal drug absorption requires more in vivo biopharmaceutical data: experience from in vivo dissolution and permeability studies in humans.
    Lennernäs H
    Curr Drug Metab; 2007 Oct; 8(7):645-57. PubMed ID: 17979653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Excipients with specialized functions for effective drug delivery.
    Hamman J; Steenekamp J
    Expert Opin Drug Deliv; 2012 Feb; 9(2):219-30. PubMed ID: 22196483
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion.
    Li M; Si L; Pan H; Rabba AK; Yan F; Qiu J; Li G
    Int J Pharm; 2011 Jan; 403(1-2):37-45. PubMed ID: 20969937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PBPK models for the prediction of in vivo performance of oral dosage forms.
    Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
    Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absorption enhancers: applications and advances.
    Aungst BJ
    AAPS J; 2012 Mar; 14(1):10-8. PubMed ID: 22105442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Caco-2 cell monolayers in prediction of intestinal drug absorption.
    Shah P; Jogani V; Bagchi T; Misra A
    Biotechnol Prog; 2006; 22(1):186-98. PubMed ID: 16454510
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biowaiver monographs for immediate release solid oral dosage forms: isoniazid.
    Becker C; Dressman JB; Amidon GL; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Barends DM;
    J Pharm Sci; 2007 Mar; 96(3):522-31. PubMed ID: 17117431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Application of a statistical method to the absorption of a new model drug from micellar and lipid formulations--evaluation of qualitative excipient effects.
    Kuentz M; Wyttenbach N; Kuhlmann O
    Pharm Dev Technol; 2007; 12(3):275-83. PubMed ID: 17613891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The gut in the beaker: Missing the surfactants?
    Wilson CG; Halbert GW; Mains J
    Int J Pharm; 2016 Nov; 514(1):73-80. PubMed ID: 27863685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Setting bioequivalence requirements for drug development based on preclinical data: optimizing oral drug delivery systems.
    Lipka E; Amidon GL
    J Control Release; 1999 Nov; 62(1-2):41-9. PubMed ID: 10518633
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats.
    Lin Y; Shen Q; Katsumi H; Okada N; Fujita T; Jiang X; Yamamoto A
    Biol Pharm Bull; 2007 Jul; 30(7):1301-7. PubMed ID: 17603171
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.
    Chow EC; Talattof A; Tsakalozou E; Fan J; Zhao L; Zhang X
    AAPS J; 2016 Nov; 18(6):1500-1511. PubMed ID: 27520379
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Pluronic F68 and Labrasol on the intestinal absorption and pharmacokinetics of rifampicin in rats.
    Ma L; Wei Y; Zhou Y; Ma X; Wu X
    Arch Pharm Res; 2011 Nov; 34(11):1939-43. PubMed ID: 22139693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solid lipid excipients - matrix agents for sustained drug delivery.
    Rosiaux Y; Jannin V; Hughes S; Marchaud D
    J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
    Porter CJ; Trevaskis NL; Charman WN
    Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and in vitro evaluation of a self-emulsifying drug delivery system (SEDDS) for oral vancomycin administration.
    Zaichik S; Steinbring C; Caliskan C; Bernkop-Schnürch A
    Int J Pharm; 2019 Jan; 554():125-133. PubMed ID: 30408530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.